188 related articles for article (PubMed ID: 10190789)
1. Paclitaxel-based chemotherapy for recurrent and/or metastatic head and neck squamous cell carcinoma: current and future directions.
Shin DM; Lippman SM
Semin Oncol; 1999 Feb; 26(1 Suppl 2):100-5. PubMed ID: 10190789
[TBL] [Abstract][Full Text] [Related]
2. Paclitaxel (Taxol)/ifosfamide-based chemotherapy in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
Shin DM
Semin Oncol; 2000 Feb; 27(1 Suppl 1):36-40. PubMed ID: 10697043
[TBL] [Abstract][Full Text] [Related]
3. Phase I study of paclitaxel, cisplatin, and ifosfamide in patients with recurrent or metastatic squamous cell cancer of the head and neck.
Benner SE; Lippman SM; Huber MH; Hong WK
Semin Oncol; 1995 Oct; 22(5 Suppl 12):22-5. PubMed ID: 7481857
[TBL] [Abstract][Full Text] [Related]
4. A phase I trial of radiotherapy and simultaneous 24-hour paclitaxel in patients with locally advanced head and neck squamous cell carcinoma.
Steinberg L; Hassan M; Olmsted L; Sharan V; Stepnick D; Hoppel C; Mugharbil A; Subramanyan S; McGloin B; Mackay W; Strauss M
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-51-S19-56. PubMed ID: 9427267
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxel (Taxol) for the treatment of head and neck cancer.
Forastiere AA
Semin Oncol; 1994 Oct; 21(5 Suppl 8):49-52. PubMed ID: 7939763
[TBL] [Abstract][Full Text] [Related]
6. The role of paclitaxel in the treatment of head and neck cancer.
Vokes EE; Haraf DJ; Stenson K; Stupp R; Malone D; Levin J; Weichselbaum RR
Semin Oncol; 1995 Oct; 22(5 Suppl 12):8-12. PubMed ID: 7481866
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel and cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma.
Adamo V; Ferraro G; Pergolizzi S; Sergi C; Laudani A; Settineri N; Alafaci E; Scimone A; Spano F; Spitaleri G
Oral Oncol; 2004 May; 40(5):525-31. PubMed ID: 15006626
[TBL] [Abstract][Full Text] [Related]
8. Continuous infusion paclitaxel, 5-fluorouracil, and hydroxyurea with concomitant radiotherapy in patients with advanced or recurrent head and neck cancer.
Haraf DJ; Stenson K; List M; Witt ME; Weichselbaum RR; Vokes EE
Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-68-S2-71. PubMed ID: 9045341
[TBL] [Abstract][Full Text] [Related]
9. Paclitaxel in the treatment of esophageal cancer.
Weiner LM
Semin Oncol; 1999 Feb; 26(1 Suppl 2):106-8. PubMed ID: 10190790
[TBL] [Abstract][Full Text] [Related]
10. Seven-week continuous-infusion paclitaxel with concurrent radiotherapy for locally advanced head and neck squamous cell cancer: a phase I study.
Rosenthal DI; Sinard RJ; Okani O; Corak J; Kavanaugh D; Kamen B; Vuitch FM; Gazdar AF; Griener J; Frenkel EP; Carbone DP
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-67-S19-71. PubMed ID: 9427270
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel, cisplatin, and 5-fluorouracil for patients with advanced or recurrent squamous cell carcinoma of the head and neck.
Hussain M; Gadgeel S; Kucuk O; Du W; Salwen W; Ensley J
Cancer; 1999 Dec; 86(11):2364-9. PubMed ID: 10590379
[TBL] [Abstract][Full Text] [Related]
12. A phase II study of weekly paclitaxel and epirubicin in recurrent or refractory squamous cell carcinoma of the head and neck.
Wang TF; Chu SC; Kao RH; Yao CY; Li CC
Jpn J Clin Oncol; 2008 Jul; 38(7):459-63. PubMed ID: 18586668
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel in simultaneous radiochemotherapy of head and neck cancer: preclinical and clinical results.
Hoffmann W; Rodemann HP; Belka C; Budach W; Schmidberger H; Bochtler H; Heinrich V; Bamberg M
Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-72-S2-77. PubMed ID: 9045342
[TBL] [Abstract][Full Text] [Related]
14. Combined modalities in the treatment of head and neck cancers.
Aisner J; Hiponia D; Conley B; Jacobs M; Gray W; Belani CP
Semin Oncol; 1995 Jun; 22(3 Suppl 6):28-34. PubMed ID: 7541154
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel in head and neck and other cancers: future prospects.
Aisner J; Cortés-Funes H
Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-113-S2-115. PubMed ID: 9045328
[TBL] [Abstract][Full Text] [Related]
16. Hydroxyurea with continuous infusion paclitaxel, 5-fluorouracil, and concomitant radiotherapy for poor-prognosis head and neck cancer.
Vokes EE; Stupp R; Haraf D; Moran W; Malone D; Wenig B; Sweeney P; Weichselbaum RR
Semin Oncol; 1995 Jun; 22(3 Suppl 6):47-52. PubMed ID: 7597433
[TBL] [Abstract][Full Text] [Related]
17. Taxoids in head and neck cancer: the American approach.
Forastiere AA
Acta Otorhinolaryngol Belg; 1999; 53(3):253-7. PubMed ID: 10635404
[TBL] [Abstract][Full Text] [Related]
18. Evidence-based radiation oncology in head and neck squamous cell carcinoma.
Corvò R
Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300
[TBL] [Abstract][Full Text] [Related]
19. A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007.
Worden FP; Moon J; Samlowski W; Clark JI; Dakhil SR; Williamson S; Urba SG; Ensley J; Hussain MH;
Cancer; 2006 Jul; 107(2):319-27. PubMed ID: 16779801
[TBL] [Abstract][Full Text] [Related]
20. Reirradiation: exploring new territory in the therapy of recurrent head and neck cancer.
Langer C; Damsker J; Ridge A
Clin Adv Hematol Oncol; 2003 Jul; 1(7):424-9, 440. PubMed ID: 16258428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
